Oncolytics Biotech Inc. (NASDAQ:ONCY) has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration or FDA for REOLYSIN for the treatment of high grade gliomas or HGG in pediatric patients. Oncolytics has conducted three previous clinical trials in brain cancers including gliomas, and has found that REOLYSIN can infect a variety of brain tumors when delivered intravenously. On Friday shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) closed at $0.42.
On Feb. 5, Maxwell Technologies, Inc. (NASDAQ:MXWL) reported revenue of $52.9 million for its fourth quarter ended December 31, 2014, up 36 percent from the $39.0 million recorded in the same period in 2013. Revenue for the fiscal year ended December 31, 2014 totaled $186.6 million, down 4 percent from the $193.5 million recorded in fiscal 2013. Maxwell Technologies, Inc. (NASDAQ:MXWL) in last trading activity fell -14.67% to close at $7.04. Company weekly performance is -11.56% while its quarterly performance stands at -37.92%. Maxwell Technologies, Inc. (NASDAQ:MXWL) is -61.80% away from its 52 week high.
CPI Aerostructures, Inc. (NYSE MKT:CVU) announced that its management presented at the Cowen and Company 36th Annual Aerospace/Defense Conference on Wednesday, February 4, 2015 at 9:00 am ET at The New York Palace Hotel, in New York. On last trading day CPI Aerostructures Inc. (NYSEMKT:CVU) fell -1.79% to close at $11.51. Its volatility for the week is 4.98% while volatility for the month is 3.72%. CVU’s sales growth for past 5 years was 18.40% and its EPS growth for past 5 years was 16.70%. CPI Aerostructures Inc. (NYSEMKT:CVU) monthly performance is 1.32%.
On Jan. 26, Methanex Corporation (NASDAQ:MEOH) announced that on January 24th, 2015, the company successfully produced first methanol from its new 1.0 million tonne plant in Geismar, Louisiana. The plant was relocated from the Company’s production site in Punta Arenas, Chile. Methanex Corporation (NASDAQ:MEOH) has institutional ownership stands at 74.80%. In last trading activity company’s stock closed at $50.50.
Home Properties Inc. (NYSE:HME) on Friday reported a key measure of profitability in its fourth quarter. The results missed Wall Street expectations. The Rochester, New York-based real estate investment trust said it had funds from operations of $78.9 million, or $1.16 per share, in the period. On last trading day Home Properties Inc. (NYSE:HME) fell -4.19% to close at $69.67. Its volatility for the week is 2.53% while volatility for the month is 1.81%. HME’s sales growth for past 5 years was 7.10% and its EPS growth for past 5 years was 32.60%. Home Properties Inc. (NYSE:HME) monthly performance is 1.24%.